[Mood disorders].
Passerieux
Christine
C
Service psychiatrie, hôpital André-Mignot, Le Chesnay Cedex, France. cpasserieux@ch-versailles.fr
Hardy-Baylé
Marie-Christine
MC
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D014151:Anti-Anxiety Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000929:Antidepressive Agents, Tricyclic / Q000008:administration & dosage / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy; D001714:Bipolar Disorder / Q000175:diagnosis; D003511:Cyclohexanols / Q000008:administration & dosage / Q000627:therapeutic use; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000523:psychology / Q000628:therapy; D003937:Diagnosis, Differential; D004359:Drug Therapy, Combination; D004565:Electroconvulsive Therapy; D005260:Female; D006760:Hospitalization; D006801:Humans; D008297:Male; D019964:Mood Disorders / Q000175:diagnosis / Q000188:drug therapy / Q000523:psychology / Q000628:therapy; D010554:Personality Disorders / Q000175:diagnosis; D011247:Pregnancy; D011379:Prognosis; D011613:Psychotherapy; D011619:Psychotropic Drugs / Q000008:administration & dosage / Q000627:therapeutic use; D012008:Recurrence; D012559:Schizophrenia / Q000175:diagnosis; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D013405:Suicide; D013997:Time Factors; D000069470:Venlafaxine Hydrochloride; D055815:Young Adult
D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D003511:Cyclohexanols; D011619:Psychotropic Drugs; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride